chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After about 15 min: hr went to over 170bpm , flushed sensation, brain fog, was driving at the time and my brain wouldn?t figure out how to call 911 , eventually I figured it out but it took extreme mental effort. Paramedics came and my pulse was From 100 - 170 changing rapidly, bp 150-175/x changing rapidly, symptoms would come and go about 8 times on way to hospital. In ER same thing then about 2 hrs go by and then all started again. Pulse remained at 90- 100bpm at least until 2am. (My resting hr is between 40 and 50, my normal bp is usually sub 120/80) I later realized my hands were swollen, mostly on my left side. Lingering symptoms include brain fog, tiredness, and headache. Maybe an exasperating issue was I had low potassium levels likely making symptoms worse - I worked out heavily early in the morning, probably had low intake of potassium that day and day before, and maybe slightly dehydrated from my workout - I do Functional lifting, run, and other types of exercise regularly.
This spontaneous report as received from a nurse practitioner refers to 2 unspecified patients of unknown age. The patients were vaccinated with a dose of MMR II (doses, routes not reported) (lot number reported as 0686AE, expiration date 02-APR-2014) on 28-JAN-2013, that was exposed to 60F for 19 hours on 27-JAN-2013. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
no additional adverse effect reported; expired Varivax administered; This spontaneous report was received from a nurse and refers to a patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 19-JUN-2020, the patient was vaccinated subcutaneously with a first dose of varicella virus vaccine live (oka/merck)(VARIVAX) (exact dose, lot number and expiration date were not reported) for prophylaxis. On 21-JUL-2020, the patient was vaccinated subcutaneously with a second dose of properly stored but expired varicella virus vaccine live (oka/merck)(VARIVAX) lot # R010468, expiration date 10-APR-2020 (exact dose was not reported). The vaccine was reconstituted with properly stored and not expired sterile diluent. No additional adverse effect reported.
5/8 Mom reported site of varicella was hot, red and raised and had jagged edges. Size of golf ball. Symptoms started the next day after vaccine. Mom started BENADRYL. 5/9/08 mom reported area looked better, size of quarter now.
Day after vaccination patient presented with circle red inflamed rash on area of vaccination. No fever, nor pain.
Within 12 hrs, I experienced severe headache and over the course of the next 5-7 days I had flu like symptoms. I did see my PCP, and was out of work for the week. I had 2 Covid 19 tests done. Both were negative. FYI- I am not a clinician, but I am considered essential personnel. My reason for reporting is that I have chronic daily headaches w/wo migraines. There are times when my headaches/migraines are manageable and other times when they are debilitating. In January and early February, my headaches/migraines were manageable. At that time, I was dealing more with my ulcerative colitis. However, I have noticed that my headaches/migraines have been more severe and debilitating in March through current. I do not know if this is my "normal" or if it is in response to the second Covid 19 vaccination I received. I was speaking w/ my supervisor, and we realized I have missed a lot of time from work due to headaches/ migraines in March/April then I had in the preceding months. I did research the internet,  but could not find a list of post vaccine side effects/ reactions, etc. but could not find any. So, I contacted nurse line. . While speaking to the nurse, she suggested I complete a report on this site.
Fever over 101 with Tylenol, Nausea, headache and dizziness for about 24 hrs.
MD called patient parent to let her know patient was given DTaP instead of TDap, no adverse reaction noted.
high temp, arms swollen shoulder to wrist, dizzy, painful from shoulder down to wrist;unable to use arm 4 days
patient broke out in hives and had to go to hospital for treatment. Ended up needing oral steroid treatment
First shot had prickly feelings like someone touching me with a pin.  I was advised I could receive 2nd shot.  Evening of second shot, left toe tingling.  pins and needles developed mainly left side but occasionally the right side.  Feet, legs, arms, fingers.   Muscle weakness also developed.   Also arms burned on biceps.   Things seem to be improving but still have paresthesia that comes and goes.
Chills; muscle spasms; shaking; throwing up; Upset stomach; This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient.  A 40 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 26Mar2021 11:00 (Lot number: EP6955) at the age of 40 years as dose 2, single for covid-19 immunization. Relevant medical history included: "Asthma" (unspecified if ongoing); "hypo thalassemia" (unspecified if ongoing). Concomitant medications included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; QVAR REDIHALER; ATIVAN. Past drug history included: Percocet, reaction: "allergies". Vaccination history included: BNT162B2 (Dose 1, Lot number: N6204, Administration time: 11:00 AM), administration date: 03Mar2021, when the patient was 40 years old, for covid-19 immunization, reaction: "Achy Joints". The following information was reported: CHILLS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "Chills"; MUSCLE SPASMS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "muscle spasms"; TREMOR (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "shaking"; VOMITING (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "throwing up"; ABDOMINAL DISCOMFORT (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "Upset stomach". Therapeutic measures were not taken as a result of chills, muscle spasms, tremor, vomiting and abdominal discomfort.  Additional information: Adverse events for second vaccine were chills, muscle spasms, shaking, and throwing up, lasted for 3 hours. Upset stomach for a few days. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.   No follow-up attempts are possible. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-2021343178 same patient/reporter/drug in separate time
Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported. No treatment information provided.
Noted with documentation that dose given to patient was not same as advised given age group.  LOT # 064A22A was advised for .5mL for young ones aged 6-11,  patient was given .25 mL at age 4.  Immunization center contacted, advised to notify mother, continue with dose 2 in series in age indicated vaccine vial. No adverse reactions anticipated. Also instructed to complete VAERS report.
Patient was due for Dtap and IPV and was given kinrix. Patient had no adverse reactions or symptoms, patient tolerated injection fine. CMA has made incident report with clinic and explained exactly what had happened and has followed guidelines for reporting to alertiis.
30 minutes after receiving my heart was racing and my chest felt tight. My symptoms progressed to severe arm pain and warm fatigue fever pain nausea diarrhea dizziness I was in bed for 2 days.
breast milk dried up w/in 2 days of getting vax;breastfeeding since 1st delivery on 8/15/98;got 2 subsequent anthrax shots on 4/29 & 5/13/99;
Information has been received from a female consumer concerning herself and her husband, both "in their sixties", who on 18-OCT-2007 were vaccinated with Zostavax (Oka/Merck).  On 17-JAN-2008 the female consumer reported she developed symptoms of shingles.  At the time of reporting the female consumer stated she was" taking VALTREX and pain medication, battling the virus".  It was also noted that her husband showed no symptoms at the time of reporting.  Additional information has been requested.
Approximately 20" after flu vaccine, pt was waiting/being monitored for possible side effects from the vaccine. After advising client she could leave, she stated her tongue was feeling itchy and throat was feeling weird. A few minutes later she also began to c/o her head itching. Returned her to the treatment room for further evaluation.AAOx3. Calm. Speech clear and appropriate. Ambulates without difficulty. Skin warm/dry. No obvious swelling of tongue or throat. Lungs clear to auscultation all fields. VS: 150/80-60-18-96.9F within normal range except for BP which was 150/80. Client reports she has a h/o HTN and she took her prescribed medication (HCTZ) this am. Also reports an allergy to lisinopril (hives)  Also reports an allergy to lisinopril (hives) and a sensitivity to wheat, cornmeal, aloe, avocado and gluten. Client reports her symptoms (itchy tongue and throat feeling weird) were beginning to subside. Administered Diphenhydramine 25mg as per RNP Flow Sheet 408.24. Continued to monitor pt for an additional 30 minutes. Denies any further symptoms. Advised to seek medical advice from her PCP, in follow up to this event which she agreed to do. Advised to call this clinic if symptoms begin to recur and not to walk back to the clinic with recurring symptoms. Assured pt had clinic phone number.
pt recv vax 13JAN96 & 18JAN96 pt devel a moderate case of chicken pox eruptions w/about 100 eruptions;there was no fever;no further details were provided;
Post vax, pt immediately devel inject site react characterized by swelling, pain & heat. Lost 12 pounds and was 'developing GBS'. She devel cancer, is receiving chemotherapy. Hosp for unspecified tests. Per 60-Day FU: double vision 10/99; Guillain Barre Syndrome 1/2000, still have this. Have not worked since 1/2000.
After receiving BOOSTRIX and FLUZONE, complained of feeling dizzy, faint (lightheaded), short of breath, "chest tightness" within 5 minutes of vaccine. Oxygen administered, BP checked continuously, EMS called, patient to hospital alert/oriented x 3.
Shingles, 7/1/21-8/15/2021, nerve damage right side scalp, right ear, right throat inside inflammation, pain, lesions on right side of skin on neck, scalp, hair loss, balance when walking, 5 weeks plus, ER visit 7/23/21, paged ER and my GP, nerve prescription and steroids, lethargic for weeks, recovery slow over 5 weeks. Lasting scalp nerve pain now September and flare ups to ear pain, throat pain and inflammation, balance when exertion of any kind such as long walks, grocery shopping an hour or more.
Patient came back to pharmacy complaining of numbnes in left side of face and arm. In mild distress, patient admitted could be due to anxiety as she is prone to attacks, but was unsure. Patient was not exhibiting any other signs or symptoms nor did she describe anything other than the numbness. She was asked if there was any accompanying pain, but there was not. Patient was asked to sit down and blood pressure was taken multiple times in which none were significantly out of range. Patient called primary care provider who advised her to head to the ER, after which she contacted someone to come pick her up. Subsequent attempts to contact patient for follow up have been unsuccessful.
2 siblings received IPOL vaccinations, that had expired with no reported adverse event; Initial information received on 19-Sep-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves 2 patients of an unknown demographics who received ipol vaccinations, that had expired with no reported adverse event, after receiving vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 16-Sep-2022, the patient received a total dose of suspect IPV (VERO) (lot T1D482M  and expiration date: 25-Jul-2022) at a dose of 0.5ml via unknown route in unknown administration site for immunization.   On 16-Sep-2022(Latency: same day),  the reporter stated 2 siblings received ipol vaccinations, that had expired with no reported adverse event (expired product administered).   Action taken :not applicable.  It was not reported if the patient received a corrective treatment for the event.   Outcome: unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weakness; Chills; Achiness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), CHILLS (Chills), MYALGIA (Achiness) and NAUSEA (Nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), CHILLS (Chills), MYALGIA (Achiness) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weakness), CHILLS (Chills), MYALGIA (Achiness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
30 days in the refrigerator on 18JAN2023; No adverse event; Patient received expired 2nd primary dose; Patient received first Moderna dose on 22-Nov-2022 and 2nd dose on 18-Jan-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired 2nd primary dose), PRODUCT STORAGE ERROR (30 days in the refrigerator on 18JAN2023), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first Moderna dose on 22-Nov-2022 and 2nd dose on 18-Jan-2023) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: FLU VACCINE VII in November 2022. Past adverse reactions to the above products included No adverse event with FLU VACCINE VII.   On 22-Nov-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2023, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired 2nd primary dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first Moderna dose on 22-Nov-2022 and 2nd dose on 18-Jan-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (30 days in the refrigerator on 18JAN2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired 2nd primary dose), PRODUCT STORAGE ERROR (30 days in the refrigerator on 18JAN2023), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first Moderna dose on 22-Nov-2022 and 2nd dose on 18-Jan-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired 2nd primary dose), PRODUCT STORAGE ERROR (30 days in the refrigerator on 18JAN2023) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first Moderna dose on 22-Nov-2022 and 2nd dose on 18-Jan-2023).    Concomitant and treatment medications were not reported.  The patient received expired 2nd primary dose of Moderna COVID-19 vaccine beyond 30 days in the refrigerator on 18-Jan-2023. The patient did not have any other vaccine on 18-Jan-2023 or 4 weeks prior to 18-Jan-2023. Parents have not reported any adverse reactions.  Monovalent Lot number: AR9236 and MFG EXP Date: 23-Feb-2023 Individual vial in the refrigerator with vial size of 2.5 ml (6M-5Y Vial). Date the vial was initially stored in the refrigerator: 14-Dec-2022 The vial did not undergo any temperature excursions.
Covid-19; Covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (pregnant) received BNT162b2 (BNT162B2), in May2021 as dose 1, single (Batch/Lot number: unknown), in Jun2021 as dose 2, single (Batch/Lot number: unknown) and in Nov2021 as dose 3, (booster) single (Batch/Lot number: unknown) at the age of 35 years, in left arm for covid-19 immunisation. Date of last menstrual period: 08Nov2021. The patient was 29  pregnant at the event onset. The patient is expected to deliver a baby(s) on 15Aug2022. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant) with onset May2022, outcome "unknown", COVID-19 (medically significant) with onset May2022, outcome "recovering" and all described as "Covid-19". Therapeutic measures were taken as a result of covid-19.  Clinical Course: last menstrual date: 08Nov2021, delivery date: 15Aug2022, gestational period: 29. Anti-viral details: product COVID 19 Treatment, Paxlovid, start on 18May2022 from 22May2022,  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cough; Face feels like red/irritated; Face feels like red/irritated; Body Ache; Nausea; Fever; Arm where they put the injection really hurts and cant raise it; Muscle pain; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), ERYTHEMA (Face feels like red/irritated), SKIN IRRITATION (Face feels like red/irritated), PAIN (Body Ache) and NAUSEA (Nausea) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced COUGH (Cough), ERYTHEMA (Face feels like red/irritated), SKIN IRRITATION (Face feels like red/irritated), PAIN (Body Ache), NAUSEA (Nausea), PYREXIA (Fever), VACCINATION SITE PAIN (Arm where they put the injection really hurts and cant raise it), MYALGIA (Muscle pain), FATIGUE (Fatigue) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, COUGH (Cough), ERYTHEMA (Face feels like red/irritated), SKIN IRRITATION (Face feels like red/irritated), PAIN (Body Ache), NAUSEA (Nausea), PYREXIA (Fever), VACCINATION SITE PAIN (Arm where they put the injection really hurts and cant raise it), MYALGIA (Muscle pain), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
superficial thrombophlebitis; This is a spontaneous report from a contactable nurse on behalf of a doctor and other health care professional via medical information team. A 55-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration in arm on 25Apr2021 (at the age of 55-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) taken for asthma, start and stop date were not reported. It was reported that he has a patient, male with no medical history. The patient got his second Pfizer COVID vaccine on 25Apr2021. The patient came in "yesterday" (03Jul2021) with superficial thrombophlebitis. He has a blood clot in his varicose vein. They did a doppler to rule out a DVT, and it was negative. The doctor was wondering if the patient was supposed to be treated with an anticoagulant. The doctor thought it was related to the vaccine. The patient noticed it "yesterday" and came into the office. The doppler was negative, but he has a positive superficial clot. The patient did come back "today" for follow up. They did not know the seriousness. The patient got the first vaccine on 30Mar2021 (at the age of 55-year-old). She does not know which arms the patient got the vaccine in. The outcome of superficial thrombophlebitis was reported as resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
1 dose of Moderna COVID 19 vaccine given to a patient who is 13 years old.; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1 dose of Moderna COVID 19 vaccine given to a patient who is 13 years old.) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1 dose of Moderna COVID 19 vaccine given to a patient who is 13 years old.). On 10-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1 dose of Moderna COVID 19 vaccine given to a patient who is 13 years old.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication was provided Treatment medication was not provided by the reporter